Walter J. (Wally) Curran, Jr. said he would step down as executive director of Winship Cancer Institute of Emory University to serve as the global chief medical officer of GenesisCare, an international group described as “the world’s largest provider of radiation oncology care and a major global provider of other medical services.”
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
